nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—ALB—multiple sclerosis	0.427	1	CbGaD
Bismuth Subsalicylate—PTGS2—Triamcinolone—multiple sclerosis	0.125	0.321	CbGbCtD
Bismuth Subsalicylate—PTGS2—Betamethasone—multiple sclerosis	0.108	0.276	CbGbCtD
Bismuth Subsalicylate—ALB—Prednisone—multiple sclerosis	0.0632	0.162	CbGbCtD
Bismuth Subsalicylate—PTGS2—Dexamethasone—multiple sclerosis	0.0626	0.16	CbGbCtD
Bismuth Subsalicylate—ALB—Methotrexate—multiple sclerosis	0.0317	0.0812	CbGbCtD
Bismuth Subsalicylate—TF—pons—multiple sclerosis	0.0156	0.333	CbGeAlD
Bismuth Subsalicylate—PTGS2—leg—multiple sclerosis	0.00421	0.0903	CbGeAlD
Bismuth Subsalicylate—TF—brainstem—multiple sclerosis	0.00347	0.0743	CbGeAlD
Bismuth Subsalicylate—TF—retina—multiple sclerosis	0.00334	0.0716	CbGeAlD
Bismuth Subsalicylate—Localized exfoliation—Triamcinolone—multiple sclerosis	0.00278	0.0313	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00263	0.0636	CbGpPWpGaD
Bismuth Subsalicylate—TF—medulla oblongata—multiple sclerosis	0.00242	0.0518	CbGeAlD
Bismuth Subsalicylate—TF—midbrain—multiple sclerosis	0.00221	0.0473	CbGeAlD
Bismuth Subsalicylate—TF—spinal cord—multiple sclerosis	0.00215	0.0462	CbGeAlD
Bismuth Subsalicylate—Epigastric pain—Mitoxantrone—multiple sclerosis	0.00205	0.0231	CcSEcCtD
Bismuth Subsalicylate—TF—nervous system—multiple sclerosis	0.00182	0.0389	CbGeAlD
Bismuth Subsalicylate—TF—Platelet degranulation—PLEK—multiple sclerosis	0.00179	0.0432	CbGpPWpGaD
Bismuth Subsalicylate—TF—central nervous system—multiple sclerosis	0.00175	0.0375	CbGeAlD
Bismuth Subsalicylate—Extravasation—Cladribine—multiple sclerosis	0.00173	0.0195	CcSEcCtD
Bismuth Subsalicylate—TF—cerebellum—multiple sclerosis	0.00171	0.0366	CbGeAlD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	0.00171	0.0411	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—S1P1 pathway—S1PR1—multiple sclerosis	0.00147	0.0354	CbGpPWpGaD
Bismuth Subsalicylate—TF—brain—multiple sclerosis	0.00139	0.0297	CbGeAlD
Bismuth Subsalicylate—Ecchymosis—Cladribine—multiple sclerosis	0.00137	0.0154	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Cladribine—multiple sclerosis	0.00127	0.0143	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Mitoxantrone—multiple sclerosis	0.00114	0.0128	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Cladribine—multiple sclerosis	0.00112	0.0126	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTPRK—multiple sclerosis	0.00112	0.027	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.00109	0.0264	CbGpPWpGaD
Bismuth Subsalicylate—Stinging—Prednisolone—multiple sclerosis	0.00101	0.0113	CcSEcCtD
Bismuth Subsalicylate—Infection—Fingolimod—multiple sclerosis	0.000944	0.0106	CcSEcCtD
Bismuth Subsalicylate—Stinging—Triamcinolone—multiple sclerosis	0.000925	0.0104	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Cladribine—multiple sclerosis	0.000909	0.0102	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Mitoxantrone—multiple sclerosis	0.000898	0.0101	CcSEcCtD
Bismuth Subsalicylate—Stinging—Betamethasone—multiple sclerosis	0.000839	0.00944	CcSEcCtD
Bismuth Subsalicylate—Stinging—Dexamethasone—multiple sclerosis	0.000839	0.00944	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Mitoxantrone—multiple sclerosis	0.000837	0.00942	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000837	0.159	CbGdCrCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000829	0.02	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.000823	0.156	CbGdCrCtD
Bismuth Subsalicylate—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000823	0.156	CbGdCrCtD
Bismuth Subsalicylate—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.000804	0.153	CbGdCrCtD
Bismuth Subsalicylate—Epistaxis—Cladribine—multiple sclerosis	0.000797	0.00897	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.000794	0.0191	CbGpPWpGaD
Bismuth Subsalicylate—Extravasation—Betamethasone—multiple sclerosis	0.000779	0.00877	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Dexamethasone—multiple sclerosis	0.000779	0.00877	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Azathioprine—multiple sclerosis	0.000739	0.00831	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Prednisolone—multiple sclerosis	0.000736	0.00829	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Mitoxantrone—multiple sclerosis	0.000724	0.00814	CcSEcCtD
Bismuth Subsalicylate—ALB—brain—multiple sclerosis	0.000722	0.0155	CbGeAlD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TBX21—multiple sclerosis	0.00072	0.0174	CbGpPWpGaD
Bismuth Subsalicylate—Erythema multiforme—Cladribine—multiple sclerosis	0.000717	0.00807	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Triamcinolone—multiple sclerosis	0.000715	0.00805	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Methylprednisolone—multiple sclerosis	0.000714	0.00803	CcSEcCtD
Bismuth Subsalicylate—Burning sensation—Methotrexate—multiple sclerosis	0.000712	0.00801	CcSEcCtD
Bismuth Subsalicylate—Lung disorder—Methotrexate—multiple sclerosis	0.000699	0.00787	CcSEcCtD
Bismuth Subsalicylate—PTGS2—medulla oblongata—multiple sclerosis	0.000685	0.0147	CbGeAlD
Bismuth Subsalicylate—Oesophagitis—Methylprednisolone—multiple sclerosis	0.000683	0.00769	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Triamcinolone—multiple sclerosis	0.000677	0.00762	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Methylprednisolone—multiple sclerosis	0.000676	0.00761	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Fingolimod—multiple sclerosis	0.000673	0.00757	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—SELPLG—multiple sclerosis	0.000662	0.016	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—MERTK—multiple sclerosis	0.000662	0.016	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—CD58—multiple sclerosis	0.000662	0.016	CbGpPWpGaD
Bismuth Subsalicylate—Erythema—Cladribine—multiple sclerosis	0.00066	0.00743	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Mitoxantrone—multiple sclerosis	0.000658	0.00741	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Fingolimod—multiple sclerosis	0.00065	0.00732	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	0.000649	0.0157	CbGpPWpGaD
Bismuth Subsalicylate—Skin exfoliation—Betamethasone—multiple sclerosis	0.000649	0.0073	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Dexamethasone—multiple sclerosis	0.000649	0.0073	CcSEcCtD
Bismuth Subsalicylate—PTGS1—spinal cord—multiple sclerosis	0.000639	0.0137	CbGeAlD
Bismuth Subsalicylate—PTGS1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000636	0.0153	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000636	0.0153	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Fingolimod—multiple sclerosis	0.000629	0.00708	CcSEcCtD
Bismuth Subsalicylate—PTGS2—midbrain—multiple sclerosis	0.000626	0.0134	CbGeAlD
Bismuth Subsalicylate—Oesophagitis—Dexamethasone—multiple sclerosis	0.000621	0.00699	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Betamethasone—multiple sclerosis	0.000621	0.00699	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Betamethasone—multiple sclerosis	0.000615	0.00692	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Dexamethasone—multiple sclerosis	0.000615	0.00692	CcSEcCtD
Bismuth Subsalicylate—PTGS2—spinal cord—multiple sclerosis	0.000611	0.0131	CbGeAlD
Bismuth Subsalicylate—Headache—Fingolimod—multiple sclerosis	0.000596	0.0067	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Azathioprine—multiple sclerosis	0.000583	0.00656	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Methotrexate—multiple sclerosis	0.000567	0.00638	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Mitoxantrone—multiple sclerosis	0.000567	0.00638	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Prednisone—multiple sclerosis	0.000565	0.00636	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Mitoxantrone—multiple sclerosis	0.000555	0.00625	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Cladribine—multiple sclerosis	0.000543	0.00612	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Prednisone—multiple sclerosis	0.000541	0.00609	CcSEcCtD
Bismuth Subsalicylate—Oedema—Cladribine—multiple sclerosis	0.000539	0.00607	CcSEcCtD
Bismuth Subsalicylate—PTGS1—nervous system—multiple sclerosis	0.000538	0.0115	CbGeAlD
Bismuth Subsalicylate—Infection—Cladribine—multiple sclerosis	0.000535	0.00603	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Prednisone—multiple sclerosis	0.000535	0.00602	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CBLB—multiple sclerosis	0.000529	0.0127	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—central nervous system—multiple sclerosis	0.000518	0.0111	CbGeAlD
Bismuth Subsalicylate—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	0.000515	0.0124	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—nervous system—multiple sclerosis	0.000515	0.011	CbGeAlD
Bismuth Subsalicylate—Anorexia—Cladribine—multiple sclerosis	0.000514	0.00578	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000505	0.0958	CbGdCrCtD
Bismuth Subsalicylate—Lethargy—Dexamethasone—multiple sclerosis	0.000503	0.00567	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Betamethasone—multiple sclerosis	0.000503	0.00567	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Mitoxantrone—multiple sclerosis	0.000499	0.00561	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000497	0.0942	CbGdCrCtD
Bismuth Subsalicylate—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000497	0.0942	CbGdCrCtD
Bismuth Subsalicylate—TF—EPHB forward signaling—MAPK1—multiple sclerosis	0.000496	0.012	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—central nervous system—multiple sclerosis	0.000495	0.0106	CbGeAlD
Bismuth Subsalicylate—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000485	0.0921	CbGdCrCtD
Bismuth Subsalicylate—PTGS2—cerebellum—multiple sclerosis	0.000484	0.0104	CbGeAlD
Bismuth Subsalicylate—Somnolence—Cladribine—multiple sclerosis	0.000479	0.00539	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Methotrexate—multiple sclerosis	0.000472	0.00532	CcSEcCtD
Bismuth Subsalicylate—Asthma—Triamcinolone—multiple sclerosis	0.00047	0.00529	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Cladribine—multiple sclerosis	0.000468	0.00527	CcSEcCtD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000467	0.0113	CbGpPWpGaD
Bismuth Subsalicylate—Weight increased—Prednisolone—multiple sclerosis	0.000465	0.00523	CcSEcCtD
Bismuth Subsalicylate—Constipation—Cladribine—multiple sclerosis	0.000461	0.00519	CcSEcCtD
Bismuth Subsalicylate—Pain—Cladribine—multiple sclerosis	0.000461	0.00519	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet degranulation—ALB—multiple sclerosis	0.00045	0.0109	CbGpPWpGaD
Bismuth Subsalicylate—Ecchymosis—Methotrexate—multiple sclerosis	0.000447	0.00503	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Cladribine—multiple sclerosis	0.000444	0.005	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Prednisone—multiple sclerosis	0.000438	0.00494	CcSEcCtD
Bismuth Subsalicylate—Infection—Azathioprine—multiple sclerosis	0.000435	0.0049	CcSEcCtD
Bismuth Subsalicylate—Erythema—Mitoxantrone—multiple sclerosis	0.000434	0.00489	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000429	0.0103	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—ALB—multiple sclerosis	0.000429	0.0103	CbGpPWpGaD
Bismuth Subsalicylate—TF—Differentiation Pathway—TGFB1—multiple sclerosis	0.000429	0.0103	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—multiple sclerosis	0.000428	0.0103	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Cladribine—multiple sclerosis	0.000428	0.00482	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Triamcinolone—multiple sclerosis	0.000428	0.00481	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Methylprednisolone—multiple sclerosis	0.000427	0.0048	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Cladribine—multiple sclerosis	0.000426	0.0048	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Mitoxantrone—multiple sclerosis	0.000425	0.00478	CcSEcCtD
Bismuth Subsalicylate—PTGS1—brain—multiple sclerosis	0.000411	0.00882	CbGeAlD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.00041	0.00988	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—PLEK—multiple sclerosis	0.000409	0.00987	CbGpPWpGaD
Bismuth Subsalicylate—ALB—HDL-mediated lipid transport—APOE—multiple sclerosis	0.0004	0.00964	CbGpPWpGaD
Bismuth Subsalicylate—Epistaxis—Triamcinolone—multiple sclerosis	0.000395	0.00445	CcSEcCtD
Bismuth Subsalicylate—PTGS2—brain—multiple sclerosis	0.000393	0.00843	CbGeAlD
Bismuth Subsalicylate—Weight increased—Dexamethasone—multiple sclerosis	0.000388	0.00437	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Betamethasone—multiple sclerosis	0.000388	0.00437	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Cladribine—multiple sclerosis	0.000381	0.00429	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Methylprednisolone—multiple sclerosis	0.000373	0.0042	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Cladribine—multiple sclerosis	0.000369	0.00415	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Methotrexate—multiple sclerosis	0.000366	0.00412	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Azathioprine—multiple sclerosis	0.000361	0.00406	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Mitoxantrone—multiple sclerosis	0.000357	0.00402	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Cladribine—multiple sclerosis	0.000356	0.00401	CcSEcCtD
Bismuth Subsalicylate—Erythema—Prednisolone—multiple sclerosis	0.000356	0.00401	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—multiple sclerosis	0.000354	0.00855	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000354	0.00854	CbGpPWpGaD
Bismuth Subsalicylate—Oedema—Mitoxantrone—multiple sclerosis	0.000354	0.00399	CcSEcCtD
Bismuth Subsalicylate—Infection—Mitoxantrone—multiple sclerosis	0.000352	0.00396	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Azathioprine—multiple sclerosis	0.000346	0.0039	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—multiple sclerosis	0.000345	0.00831	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Cladribine—multiple sclerosis	0.000343	0.00386	CcSEcCtD
Bismuth Subsalicylate—Rash—Cladribine—multiple sclerosis	0.00034	0.00382	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Betamethasone—multiple sclerosis	0.00034	0.00382	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Dexamethasone—multiple sclerosis	0.00034	0.00382	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Cladribine—multiple sclerosis	0.000339	0.00382	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Prednisone—multiple sclerosis	0.000338	0.0038	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Mitoxantrone—multiple sclerosis	0.000338	0.0038	CcSEcCtD
Bismuth Subsalicylate—Headache—Cladribine—multiple sclerosis	0.000338	0.0038	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Biological oxidations—CYP27B1—multiple sclerosis	0.000338	0.00814	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Biological oxidations—CYP24A1—multiple sclerosis	0.000338	0.00814	CbGpPWpGaD
Bismuth Subsalicylate—Erythema—Triamcinolone—multiple sclerosis	0.000327	0.00369	CcSEcCtD
Bismuth Subsalicylate—Erythema—Methylprednisolone—multiple sclerosis	0.000327	0.00368	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet degranulation—PLEK—multiple sclerosis	0.000326	0.00786	CbGpPWpGaD
Bismuth Subsalicylate—TF—Differentiation Pathway—IL6—multiple sclerosis	0.000323	0.00779	CbGpPWpGaD
Bismuth Subsalicylate—Dysgeusia—Triamcinolone—multiple sclerosis	0.000321	0.00361	CcSEcCtD
Bismuth Subsalicylate—Nausea—Cladribine—multiple sclerosis	0.00032	0.0036	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—multiple sclerosis	0.000316	0.00762	CbGpPWpGaD
Bismuth Subsalicylate—Somnolence—Mitoxantrone—multiple sclerosis	0.000315	0.00354	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000312	0.00351	CcSEcCtD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	0.000311	0.00749	CbGpPWpGaD
Bismuth Subsalicylate—Asthma—Methotrexate—multiple sclerosis	0.00031	0.00349	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MBP—multiple sclerosis	0.000308	0.00743	CbGpPWpGaD
Bismuth Subsalicylate—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000308	0.00347	CcSEcCtD
Bismuth Subsalicylate—Constipation—Mitoxantrone—multiple sclerosis	0.000303	0.00341	CcSEcCtD
Bismuth Subsalicylate—Pain—Mitoxantrone—multiple sclerosis	0.000303	0.00341	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Azathioprine—multiple sclerosis	0.0003	0.00337	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000298	0.00335	CcSEcCtD
Bismuth Subsalicylate—Erythema—Dexamethasone—multiple sclerosis	0.000297	0.00334	CcSEcCtD
Bismuth Subsalicylate—Erythema—Betamethasone—multiple sclerosis	0.000297	0.00334	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Prednisone—multiple sclerosis	0.000296	0.00333	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—multiple sclerosis	0.000295	0.00711	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000292	0.00329	CcSEcCtD
Bismuth Subsalicylate—Oedema—Prednisolone—multiple sclerosis	0.000291	0.00327	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Azathioprine—multiple sclerosis	0.00029	0.00326	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—SELE—multiple sclerosis	0.000288	0.00695	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—TGFB1—multiple sclerosis	0.000285	0.00687	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Mitoxantrone—multiple sclerosis	0.000281	0.00317	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00028	0.00315	CcSEcCtD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00028	0.00675	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Azathioprine—multiple sclerosis	0.000279	0.00314	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Methotrexate—multiple sclerosis	0.000277	0.00311	CcSEcCtD
Bismuth Subsalicylate—Rash—Azathioprine—multiple sclerosis	0.000276	0.00311	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.000276	0.00666	CbGpPWpGaD
Bismuth Subsalicylate—Dermatitis—Azathioprine—multiple sclerosis	0.000276	0.00311	CcSEcCtD
Bismuth Subsalicylate—Headache—Azathioprine—multiple sclerosis	0.000275	0.00309	CcSEcCtD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	0.000271	0.00654	CbGpPWpGaD
Bismuth Subsalicylate—Confusional state—Methylprednisolone—multiple sclerosis	0.000269	0.00303	CcSEcCtD
Bismuth Subsalicylate—Oedema—Triamcinolone—multiple sclerosis	0.000267	0.00301	CcSEcCtD
Bismuth Subsalicylate—Infection—Triamcinolone—multiple sclerosis	0.000266	0.00299	CcSEcCtD
Bismuth Subsalicylate—Infection—Methylprednisolone—multiple sclerosis	0.000265	0.00298	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Methotrexate—multiple sclerosis	0.000261	0.00294	CcSEcCtD
Bismuth Subsalicylate—Nausea—Azathioprine—multiple sclerosis	0.00026	0.00293	CcSEcCtD
Bismuth Subsalicylate—Erythema—Prednisone—multiple sclerosis	0.000259	0.00291	CcSEcCtD
Bismuth Subsalicylate—Pain—Prednisolone—multiple sclerosis	0.000249	0.0028	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Methotrexate—multiple sclerosis	0.000248	0.0028	CcSEcCtD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000248	0.00597	CbGpPWpGaD
Bismuth Subsalicylate—Oedema—Dexamethasone—multiple sclerosis	0.000242	0.00273	CcSEcCtD
Bismuth Subsalicylate—Oedema—Betamethasone—multiple sclerosis	0.000242	0.00273	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000242	0.00273	CcSEcCtD
Bismuth Subsalicylate—Infection—Dexamethasone—multiple sclerosis	0.000241	0.00271	CcSEcCtD
Bismuth Subsalicylate—Infection—Betamethasone—multiple sclerosis	0.000241	0.00271	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Prednisolone—multiple sclerosis	0.000239	0.0027	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—TNF—multiple sclerosis	0.000238	0.00575	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Triamcinolone—multiple sclerosis	0.000235	0.00265	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Methotrexate—multiple sclerosis	0.000235	0.00264	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000235	0.00264	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—AQP4—multiple sclerosis	0.000233	0.00563	CbGpPWpGaD
Bismuth Subsalicylate—Tinnitus—Methotrexate—multiple sclerosis	0.000232	0.00261	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Dexamethasone—multiple sclerosis	0.000231	0.0026	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Betamethasone—multiple sclerosis	0.000231	0.0026	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Prednisolone—multiple sclerosis	0.000231	0.0026	CcSEcCtD
Bismuth Subsalicylate—ALB—Lipoprotein metabolism—APOE—multiple sclerosis	0.00023	0.00554	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—multiple sclerosis	0.000229	0.00553	CbGpPWpGaD
Bismuth Subsalicylate—Pain—Triamcinolone—multiple sclerosis	0.000229	0.00257	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Mitoxantrone—multiple sclerosis	0.000225	0.00254	CcSEcCtD
Bismuth Subsalicylate—Rash—Mitoxantrone—multiple sclerosis	0.000223	0.00251	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Mitoxantrone—multiple sclerosis	0.000223	0.00251	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—multiple sclerosis	0.000223	0.00538	CbGpPWpGaD
Bismuth Subsalicylate—Headache—Mitoxantrone—multiple sclerosis	0.000222	0.0025	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00022	0.00248	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00022	0.00247	CcSEcCtD
Bismuth Subsalicylate—Erythema—Methotrexate—multiple sclerosis	0.000216	0.00243	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000215	0.00518	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Dexamethasone—multiple sclerosis	0.000213	0.0024	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Betamethasone—multiple sclerosis	0.000213	0.0024	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Triamcinolone—multiple sclerosis	0.000212	0.00239	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Methylprednisolone—multiple sclerosis	0.000212	0.00238	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Methotrexate—multiple sclerosis	0.000212	0.00238	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Triamcinolone—multiple sclerosis	0.000211	0.00238	CcSEcCtD
Bismuth Subsalicylate—Oedema—Prednisone—multiple sclerosis	0.000211	0.00238	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Betamethasone—multiple sclerosis	0.000211	0.00237	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Dexamethasone—multiple sclerosis	0.000211	0.00237	CcSEcCtD
Bismuth Subsalicylate—Nausea—Mitoxantrone—multiple sclerosis	0.00021	0.00237	CcSEcCtD
Bismuth Subsalicylate—Infection—Prednisone—multiple sclerosis	0.00021	0.00236	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—ITGA4—multiple sclerosis	0.000208	0.00503	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—multiple sclerosis	0.000208	0.00503	CbGpPWpGaD
Bismuth Subsalicylate—Pain—Betamethasone—multiple sclerosis	0.000207	0.00233	CcSEcCtD
Bismuth Subsalicylate—Pain—Dexamethasone—multiple sclerosis	0.000207	0.00233	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—IFNB1—multiple sclerosis	0.000207	0.00499	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—multiple sclerosis	0.000204	0.00493	CbGpPWpGaD
Bismuth Subsalicylate—Anorexia—Prednisone—multiple sclerosis	0.000201	0.00227	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Betamethasone—multiple sclerosis	0.0002	0.00225	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Dexamethasone—multiple sclerosis	0.0002	0.00225	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.0002	0.00482	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—S1P1 pathway—MAPK1—multiple sclerosis	0.000199	0.00479	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Betamethasone—multiple sclerosis	0.000193	0.00217	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Dexamethasone—multiple sclerosis	0.000193	0.00217	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—IL6—multiple sclerosis	0.000192	0.00464	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Prednisolone—multiple sclerosis	0.000192	0.00216	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Dexamethasone—multiple sclerosis	0.000192	0.00216	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Betamethasone—multiple sclerosis	0.000192	0.00216	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—TNF—multiple sclerosis	0.000189	0.00456	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Triamcinolone—multiple sclerosis	0.000189	0.00213	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Methylprednisolone—multiple sclerosis	0.000189	0.00212	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000187	0.00451	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Prednisone—multiple sclerosis	0.000186	0.00209	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—multiple sclerosis	0.000185	0.00447	CbGpPWpGaD
Bismuth Subsalicylate—Decreased appetite—Prednisone—multiple sclerosis	0.000184	0.00207	CcSEcCtD
Bismuth Subsalicylate—Rash—Prednisolone—multiple sclerosis	0.000183	0.00206	CcSEcCtD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—CCL5—multiple sclerosis	0.000183	0.00442	CbGpPWpGaD
Bismuth Subsalicylate—Dermatitis—Prednisolone—multiple sclerosis	0.000183	0.00206	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000182	0.00205	CcSEcCtD
Bismuth Subsalicylate—Headache—Prednisolone—multiple sclerosis	0.000182	0.00205	CcSEcCtD
Bismuth Subsalicylate—Constipation—Prednisone—multiple sclerosis	0.000181	0.00203	CcSEcCtD
Bismuth Subsalicylate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—multiple sclerosis	0.000179	0.00431	CbGpPWpGaD
Bismuth Subsalicylate—Confusional state—Methotrexate—multiple sclerosis	0.000178	0.002	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Triamcinolone—multiple sclerosis	0.000177	0.00199	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Methylprednisolone—multiple sclerosis	0.000176	0.00198	CcSEcCtD
Bismuth Subsalicylate—Infection—Methotrexate—multiple sclerosis	0.000175	0.00197	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Prednisone—multiple sclerosis	0.000174	0.00196	CcSEcCtD
Bismuth Subsalicylate—Nausea—Prednisolone—multiple sclerosis	0.000173	0.00194	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Dexamethasone—multiple sclerosis	0.000172	0.00193	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Betamethasone—multiple sclerosis	0.000172	0.00193	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Triamcinolone—multiple sclerosis	0.00017	0.00191	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Methylprednisolone—multiple sclerosis	0.00017	0.00191	CcSEcCtD
Bismuth Subsalicylate—Rash—Triamcinolone—multiple sclerosis	0.000169	0.0019	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Triamcinolone—multiple sclerosis	0.000168	0.00189	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Methotrexate—multiple sclerosis	0.000168	0.00189	CcSEcCtD
Bismuth Subsalicylate—Rash—Methylprednisolone—multiple sclerosis	0.000168	0.00189	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Methylprednisolone—multiple sclerosis	0.000168	0.00189	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Prednisone—multiple sclerosis	0.000168	0.00189	CcSEcCtD
Bismuth Subsalicylate—ALB—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000168	0.00404	CbGpPWpGaD
Bismuth Subsalicylate—Headache—Triamcinolone—multiple sclerosis	0.000167	0.00188	CcSEcCtD
Bismuth Subsalicylate—Headache—Methylprednisolone—multiple sclerosis	0.000167	0.00188	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Prednisone—multiple sclerosis	0.000167	0.00188	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Dexamethasone—multiple sclerosis	0.000166	0.00187	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Betamethasone—multiple sclerosis	0.000166	0.00187	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.000162	0.00391	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CCR2—multiple sclerosis	0.000162	0.0039	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Betamethasone—multiple sclerosis	0.00016	0.0018	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Dexamethasone—multiple sclerosis	0.00016	0.0018	CcSEcCtD
Bismuth Subsalicylate—Nausea—Triamcinolone—multiple sclerosis	0.000159	0.00179	CcSEcCtD
Bismuth Subsalicylate—Nausea—Methylprednisolone—multiple sclerosis	0.000158	0.00178	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Methotrexate—multiple sclerosis	0.000157	0.00177	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000156	0.00376	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Methotrexate—multiple sclerosis	0.000155	0.00175	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Dexamethasone—multiple sclerosis	0.000154	0.00174	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Betamethasone—multiple sclerosis	0.000154	0.00174	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Methotrexate—multiple sclerosis	0.000153	0.00173	CcSEcCtD
Bismuth Subsalicylate—Rash—Betamethasone—multiple sclerosis	0.000153	0.00172	CcSEcCtD
Bismuth Subsalicylate—Rash—Dexamethasone—multiple sclerosis	0.000153	0.00172	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Dexamethasone—multiple sclerosis	0.000153	0.00172	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Betamethasone—multiple sclerosis	0.000153	0.00172	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—IL6—multiple sclerosis	0.000153	0.00368	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	0.000153	0.00368	CbGpPWpGaD
Bismuth Subsalicylate—Headache—Betamethasone—multiple sclerosis	0.000152	0.00171	CcSEcCtD
Bismuth Subsalicylate—Headache—Dexamethasone—multiple sclerosis	0.000152	0.00171	CcSEcCtD
Bismuth Subsalicylate—Pain—Methotrexate—multiple sclerosis	0.000151	0.0017	CcSEcCtD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	0.00015	0.00362	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Prednisone—multiple sclerosis	0.000149	0.00168	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Methotrexate—multiple sclerosis	0.000145	0.00164	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.000145	0.00349	CbGpPWpGaD
Bismuth Subsalicylate—Diarrhoea—Prednisone—multiple sclerosis	0.000144	0.00163	CcSEcCtD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL4—multiple sclerosis	0.000144	0.00348	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Dexamethasone—multiple sclerosis	0.000144	0.00162	CcSEcCtD
Bismuth Subsalicylate—Nausea—Betamethasone—multiple sclerosis	0.000144	0.00162	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000143	0.00345	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—IL2RA—multiple sclerosis	0.000142	0.00343	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000142	0.00342	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	0.000141	0.0034	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Methotrexate—multiple sclerosis	0.00014	0.00158	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Prednisone—multiple sclerosis	0.00014	0.00157	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Methotrexate—multiple sclerosis	0.00014	0.00157	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	0.000135	0.00325	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CXCL10—multiple sclerosis	0.000134	0.00324	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Prednisone—multiple sclerosis	0.000134	0.00151	CcSEcCtD
Bismuth Subsalicylate—Rash—Prednisone—multiple sclerosis	0.000133	0.0015	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Prednisone—multiple sclerosis	0.000133	0.0015	CcSEcCtD
Bismuth Subsalicylate—Headache—Prednisone—multiple sclerosis	0.000132	0.00149	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00013	0.00313	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00013	0.00313	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000127	0.00306	CbGpPWpGaD
Bismuth Subsalicylate—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000127	0.00306	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.000126	0.00305	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	0.000126	0.00304	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000126	0.00303	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Prednisone—multiple sclerosis	0.000125	0.00141	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Methotrexate—multiple sclerosis	0.000125	0.00141	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000124	0.00299	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—BDNF—multiple sclerosis	0.000121	0.00291	CbGpPWpGaD
Bismuth Subsalicylate—Diarrhoea—Methotrexate—multiple sclerosis	0.000121	0.00136	CcSEcCtD
Bismuth Subsalicylate—ALB—Hemostasis—MERTK—multiple sclerosis	0.000121	0.00291	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CD58—multiple sclerosis	0.000121	0.00291	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SELPLG—multiple sclerosis	0.000121	0.00291	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	0.00012	0.00289	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000118	0.00285	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Methotrexate—multiple sclerosis	0.000117	0.00131	CcSEcCtD
Bismuth Subsalicylate—ALB—Folate Metabolism—ICAM1—multiple sclerosis	0.000115	0.00277	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000113	0.00272	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Methotrexate—multiple sclerosis	0.000112	0.00126	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL4—multiple sclerosis	0.000112	0.00271	CbGpPWpGaD
Bismuth Subsalicylate—Rash—Methotrexate—multiple sclerosis	0.000111	0.00125	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Methotrexate—multiple sclerosis	0.000111	0.00125	CcSEcCtD
Bismuth Subsalicylate—Headache—Methotrexate—multiple sclerosis	0.000111	0.00124	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000108	0.0026	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	0.000107	0.00259	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Methotrexate—multiple sclerosis	0.000105	0.00118	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—ALB—multiple sclerosis	0.000103	0.00248	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000103	0.00248	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000103	0.00248	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—CCL2—multiple sclerosis	0.000103	0.00248	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000102	0.00247	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000101	0.00243	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.0001	0.00241	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	9.79e-05	0.00236	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	9.63e-05	0.00232	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	9.57e-05	0.00231	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	9.4e-05	0.00227	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	9.32e-05	0.00225	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	9.29e-05	0.00224	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	9.12e-05	0.0022	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.91e-05	0.00215	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	8.91e-05	0.00215	CbGpPWpGaD
Bismuth Subsalicylate—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	8.87e-05	0.00214	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IFNG—multiple sclerosis	8.73e-05	0.00211	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	8.72e-05	0.0021	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	8.59e-05	0.00207	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	8.57e-05	0.00207	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.52e-05	0.00205	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—IL2—multiple sclerosis	8.35e-05	0.00201	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.33e-05	0.00201	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.33e-05	0.00201	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	8.22e-05	0.00198	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SRM—multiple sclerosis	8.19e-05	0.00198	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	8.16e-05	0.00197	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	7.97e-05	0.00192	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL1B—multiple sclerosis	7.79e-05	0.00188	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL2—multiple sclerosis	7.76e-05	0.00187	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	7.65e-05	0.00184	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Biological oxidations—POMC—multiple sclerosis	7.59e-05	0.00183	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PLEK—multiple sclerosis	7.46e-05	0.0018	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	7.03e-05	0.0017	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	6.99e-05	0.00169	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	6.95e-05	0.00168	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	6.94e-05	0.00167	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	6.78e-05	0.00164	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TGFB1—multiple sclerosis	6.51e-05	0.00157	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SRM—multiple sclerosis	6.51e-05	0.00157	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.45e-05	0.00156	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—MAPK1—multiple sclerosis	6.39e-05	0.00154	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	6.19e-05	0.00149	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	6.18e-05	0.00149	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	6.05e-05	0.00146	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	6.02e-05	0.00145	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP27B1—multiple sclerosis	5.77e-05	0.00139	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP24A1—multiple sclerosis	5.77e-05	0.00139	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	5.7e-05	0.00138	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TNF—multiple sclerosis	5.65e-05	0.00136	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.64e-05	0.00136	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	5.64e-05	0.00136	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	5.61e-05	0.00135	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	5.55e-05	0.00134	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GPC5—multiple sclerosis	5.28e-05	0.00127	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SRM—multiple sclerosis	5.26e-05	0.00127	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SELE—multiple sclerosis	5.25e-05	0.00127	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—TGFB1—multiple sclerosis	5.19e-05	0.00125	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.1e-05	0.00123	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	5.03e-05	0.00121	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—GPC5—multiple sclerosis	5.01e-05	0.00121	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	4.94e-05	0.00119	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	4.71e-05	0.00114	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	4.7e-05	0.00113	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	4.61e-05	0.00111	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP27B1—multiple sclerosis	4.58e-05	0.00111	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP24A1—multiple sclerosis	4.58e-05	0.00111	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL6—multiple sclerosis	4.56e-05	0.0011	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.51e-05	0.00109	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	4.49e-05	0.00108	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.48e-05	0.00108	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	4.48e-05	0.00108	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	4.39e-05	0.00106	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—RRM1—multiple sclerosis	4.38e-05	0.00106	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GPC5—multiple sclerosis	4.19e-05	0.00101	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—ITGA4—multiple sclerosis	3.8e-05	0.000916	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IFNB1—multiple sclerosis	3.77e-05	0.000909	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP27B1—multiple sclerosis	3.71e-05	0.000894	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP24A1—multiple sclerosis	3.71e-05	0.000894	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.62e-05	0.000874	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	3.62e-05	0.000874	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	3.54e-05	0.000854	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—RRM1—multiple sclerosis	3.47e-05	0.000838	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.39e-05	0.000819	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GPC5—multiple sclerosis	3.39e-05	0.000818	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RPL5—multiple sclerosis	3.25e-05	0.000785	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.2e-05	0.000773	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.2e-05	0.000771	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.14e-05	0.000756	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SLC11A1—multiple sclerosis	3.12e-05	0.000752	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.99e-05	0.00072	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	2.95e-05	0.000712	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.92e-05	0.000703	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—RRM1—multiple sclerosis	2.81e-05	0.000678	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.69e-05	0.00065	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.66e-05	0.000641	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IL2RA—multiple sclerosis	2.59e-05	0.000626	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—BCHE—multiple sclerosis	2.51e-05	0.000606	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CD28—multiple sclerosis	2.49e-05	0.0006	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.32e-05	0.000558	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	2.3e-05	0.000555	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	2.26e-05	0.000544	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.18e-05	0.000526	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.11e-05	0.000509	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—BCHE—multiple sclerosis	1.99e-05	0.000481	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.87e-05	0.000452	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CD86—multiple sclerosis	1.78e-05	0.000428	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—BCHE—multiple sclerosis	1.61e-05	0.000389	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CCR5—multiple sclerosis	1.58e-05	0.00038	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HLA-A—multiple sclerosis	1.54e-05	0.00037	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IL2—multiple sclerosis	1.52e-05	0.000367	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APOE—multiple sclerosis	1.51e-05	0.000365	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOE—multiple sclerosis	1.43e-05	0.000346	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—POMC—multiple sclerosis	1.3e-05	0.000313	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CD80—multiple sclerosis	1.3e-05	0.000313	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOE—multiple sclerosis	1.2e-05	0.000289	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TGFB1—multiple sclerosis	1.19e-05	0.000286	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALB—multiple sclerosis	1.18e-05	0.000286	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MAPK1—multiple sclerosis	1.16e-05	0.000281	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TYK2—multiple sclerosis	1.09e-05	0.000264	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—POMC—multiple sclerosis	1.03e-05	0.000249	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CD4—multiple sclerosis	9.89e-06	0.000239	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOE—multiple sclerosis	9.71e-06	0.000234	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALB—multiple sclerosis	9.4e-06	0.000227	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—POMC—multiple sclerosis	8.34e-06	0.000201	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—STAT3—multiple sclerosis	7.66e-06	0.000185	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MYC—multiple sclerosis	7.12e-06	0.000172	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFB1—multiple sclerosis	7.1e-06	0.000171	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MAPK1—multiple sclerosis	6.96e-06	0.000168	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6—multiple sclerosis	5.35e-06	0.000129	CbGpPWpGaD
